Силібінін (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Силібінін" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

10nih.gov

4^th place

5^th place

9doi.org

2^nd place

4^th place

1karger.com

4,489^th place

3,063^rd place

1thorne.com

low place

1elsevier.com

610^th place

819^th place

1adisonline.com

low place

adisonline.com

Pharmacology of Silymarin / Fraschini F., Demartini G., Esposti D. // Clinical Drug Investigation. — 2002. — Vol. 22. — P. 51–65. — doi:10.2165/00044011-200222010-00007.

doi.org

Milk Thistle and Prostate Cancer: Differential Effects of Pure Flavonolignans from Silybum marianum on Antiproliferative End Points in Human Prostate Carcinoma Cells / Davis-Searles P., Nakanishi Y., Nam-Cheol K. et al // Cancer Research. — 2005. — Vol. 65, no. 10. — P. 4448–57. — doi:10.1158/0008-5472.CAN-04-4662 ref=.
An updated systematic review with meta-analysis for the clinical evidence of silymarin / Saller R., Brignoli R., Melzer J., Meier R. // Forschende Komplementärmedizin. — 2008. — Vol. 15, no. 1. — P. 9–20. — doi:10.1159/000113648. — PMID 18334810.
Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems / Voinovich D., Perissutti B., Grassi M., Passerini N., Bigotto A. // Journal of Pharmaceutical Sciences. — 2009. — Vol. 98, no. 11. — P. 4119–29. — doi:10.1002/jps.21704. — PMID 19226635.
Antioxidant properties of silybin glycosides / Kosina P., Kren V., Gebhardt R., Grambal F., Ulrichová J., Walterová D. // Phytotherapy Research : PTR. — 2002. — Vol. 16 Suppl 1. — P. S33–9. — doi:10.1002/ptr.796. — PMID 11933137.
Drug-drug interactions of silymarin on the perspective of pharmacokinetics / Wu J.W., Lin L.C., Tsai T.H. // Journal of Ethnopharmacology. — 2009. — Vol. 121, no. 2. — P. 185–93. — doi:10.1016/j.jep.2008.10.036. — PMID 19041708.
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients / Thomas W. Flaig, Daniel L. Gustafson, Lih-Jen Su, Joseph A. Zirrolli, Frances Crighton, Gail S. Harrison, A. Scott Pierson, Rajesh Agarwal, L. Michael Glodé // Investigational New Drugs. — 2007. — Vol. 25, no. 2. — P. 139–146. — doi:10.1007/s10637-006-9019-2.
Pharmacology of Silymarin / Fraschini F., Demartini G., Esposti D. // Clinical Drug Investigation. — 2002. — Vol. 22. — P. 51–65. — doi:10.2165/00044011-200222010-00007.
Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy / Bosch-Barrera J., Menendez J.A. // Cancer Treat. Rev.. — 2015. — Vol. 41, no. 6. — P. 540–6. — doi:10.1016/j.ctrv.2015.04.008. — PMID 25944486.
Singh, Rana P.; Agarwal, Rajesh (September 2009). Cosmeceuticals and silibinin. Clinics in Dermatology. 27 (5): 479—484. doi:10.1016/j.clindermatol.2009.05.012. PMC 2767273. PMID 19695480.

elsevier.com

linkinghub.elsevier.com

Drug-drug interactions of silymarin on the perspective of pharmacokinetics / Wu J.W., Lin L.C., Tsai T.H. // Journal of Ethnopharmacology. — 2009. — Vol. 121, no. 2. — P. 185–93. — doi:10.1016/j.jep.2008.10.036. — PMID 19041708.

karger.com

content.karger.com

An updated systematic review with meta-analysis for the clinical evidence of silymarin / Saller R., Brignoli R., Melzer J., Meier R. // Forschende Komplementärmedizin. — 2008. — Vol. 15, no. 1. — P. 9–20. — doi:10.1159/000113648. — PMID 18334810.

nih.gov

ncbi.nlm.nih.gov

An updated systematic review with meta-analysis for the clinical evidence of silymarin / Saller R., Brignoli R., Melzer J., Meier R. // Forschende Komplementärmedizin. — 2008. — Vol. 15, no. 1. — P. 9–20. — doi:10.1159/000113648. — PMID 18334810.
A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos) / Kidd P., Head K. // Alternative Medicine Review. — 2005. — Vol. 10, no. 3. — P. 193–203. — PMID 16164374.
Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: Characterization and bioavailability of the coground systems / Voinovich D., Perissutti B., Grassi M., Passerini N., Bigotto A. // Journal of Pharmaceutical Sciences. — 2009. — Vol. 98, no. 11. — P. 4119–29. — doi:10.1002/jps.21704. — PMID 19226635.
Antioxidant properties of silybin glycosides / Kosina P., Kren V., Gebhardt R., Grambal F., Ulrichová J., Walterová D. // Phytotherapy Research : PTR. — 2002. — Vol. 16 Suppl 1. — P. S33–9. — doi:10.1002/ptr.796. — PMID 11933137.
Drug-drug interactions of silymarin on the perspective of pharmacokinetics / Wu J.W., Lin L.C., Tsai T.H. // Journal of Ethnopharmacology. — 2009. — Vol. 121, no. 2. — P. 185–93. — doi:10.1016/j.jep.2008.10.036. — PMID 19041708.
On the pharmacology and toxicology of silymarin, an antihepatotoxic active principle from Silybum marianum (L.) gaertn / Hahn G., Lehmann H.D., Kürten M., Uebel H., Vogel G. // Arzneimittelforschung. — 1968. — Вип. 6. — Vol. 18. — P. 698–704. — PMID 5755807.
Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy / Bosch-Barrera J., Menendez J.A. // Cancer Treat. Rev.. — 2015. — Vol. 41, no. 6. — P. 540–6. — doi:10.1016/j.ctrv.2015.04.008. — PMID 25944486.
Singh, Rana P.; Agarwal, Rajesh (September 2009). Cosmeceuticals and silibinin. Clinics in Dermatology. 27 (5): 479—484. doi:10.1016/j.clindermatol.2009.05.012. PMC 2767273. PMID 19695480.

pubmed.ncbi.nlm.nih.gov

Pharmacokinetic studies on IdB 1016, a silybin- phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet. 15: 333—8. 1990. PMID 2088770.
Singh, Rana P.; Agarwal, Rajesh (September 2009). Cosmeceuticals and silibinin. Clinics in Dermatology. 27 (5): 479—484. doi:10.1016/j.clindermatol.2009.05.012. PMC 2767273. PMID 19695480.

thorne.com

A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos) / Kidd P., Head K. // Alternative Medicine Review. — 2005. — Vol. 10, no. 3. — P. 193–203. — PMID 16164374.